Abstracts tagged "systemic lupus erythematosus (SLE) and exercise"

Abstract Number: 655 • 2019 ACR/ARP Annual Meeting
Assessing Perceptions, Barriers, and Preferences to Exercise in Patients with Systemic Lupus Erythematosus
Gabriel Jeyasingham¹, Arzoo Alam ¹, Nicholas Steiner ², Kimberly Legault ¹, Mark Matsos ¹ and Karen Beattie ¹, ¹McMaster University, Hamilton, ON, Canada, ²Western University, London, ON, Canada
Background/Purpose: Cardiovascular disease is a significant cause of mortality in patients with SLE. High levels of fatigue are also reported in patients with SLE and…
Abstract Number: 1595 • 2019 ACR/ARP Annual Meeting
Role of Aerobic Exercise in Modulating Fatigue in Women with Systemic Lupus Erythematosus
Marquis Chapman ¹, Sarthak Gupta², Jun Chu ¹, Mohammad Naqi ³, Zerai Manna ³, Mir Ali Mazhar ¹, Adam Munday ¹, Marybeth Stockman ⁴, Bart Dinkard ⁴, Lisa Chin ⁴, Mariana Kaplan ¹, Randall Keyser ⁵, Leighton Chan ⁴ and Sarfaraz Hasni ⁶, ¹National Institute of Arthritis, Musculoskeletal, and Skin diseases/ National Institutes of Health, Bethesda, ²Systemic Autoimmunity Branch, NIAMS, NIH, Bethesda, ³NIAMS/NIH, Bethesda, ⁴Rehabilitation Medicine Department, Clinical Center, NIH, Bethesda, ⁵Department of Rehabilitation Science, George Mason University, Bethesda, ⁶National Institute of Arthritis, Musculoskeletal, and Skin diseases/ National Institutes of Health, Bethesda, MD
Background/Purpose: Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that predominantly afflicts women. One of the most debilitating symptoms experienced by SLE patients is…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].